Pulse nav.journalClub Aktive Debatten Trends Entdecken Forschende

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Start Entdecken nav.journalClub Trends

⌘+K

© Synapse Social LLC, 2026

Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group | Synapse

May 28, 2008Open Access

Lungenadjuvante Cisplatin-Evaluation: Eine gepoolte Analyse der LACE-Kollaborationsgruppe

Key Points

Key points are not available for this paper at this time.

Abstract

Postoperative Cisplatin-basierte Chemotherapie verbessert signifikant das Überleben bei Patienten mit NSCLC.

KI fragen

Like

Bookmark

Share

View Full Paper

KI fragen

Like

Bookmark

Share

View Full Paper

Cite This Study

Pignon et al. (Mittwoch) untersuchten diese Frage.

synapsesocial.com/papers/69d7c6f005ee2ba81dbede0f https://doi.org/https://doi.org/10.1200/jco.2007.13.9030

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Cisplatin chemotherapy (without erythropoietin) and risk of life-threatening thromboembolic events in carcinoma of the uterine cervix: the tip of the iceberg? A review of the literature2006 · 30 citations
2GLOBOCAN 2000. Cancer incidence, mortality and prevalence worldwide, Version 1.02001 · 538 citations
3Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy1992 · 2,192 citations
4Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials1995 · 2,859 citations
5Adjuvant Therapy for Early Lung Cancer: Reflections and Perspectives2006 · 6 citations